Overview of the organizational structure of the UCLA ICMIC (Figure 1). Dr. Herschman is Principal Investigator of the UCLA ICMIC, Dr. Phelps will serve functionally as Co-Principal investigator, although this is no longer a recognized NIH title. Drs. Herschman and Phelps are supported by a budgeted Administrative Component that include secretarial, financial and grants preparation assistance. The ICMIC program has four Research Component projects, headed by Drs Ribas, Radu, Hong Wu and Herschman. There are three Specialized Resources. The Cyclotron and Radiochemistry Specialized Resource, directed by Dr. Satyamuthy, provides positron-emitting radiotracers for ICMIC studies. The Molecular Imaging Specialized Resource, directed by Dr. Stout, provides access to molecular imaging instrumentation as well as expertise, instruction and technical assistance in their utilization. The Quantitative Image Analysis Specialized Resource, directed by Dr Henry Huang, provides expert assistance in image interpretation and quantization, data storage and retrieval, and modeling of microPET data. The Specialized Resources provide imaging reagents, instrumentation, technical assistance, instruction and intellectual insight in support of the research efforts of the Research Component Projects, the Developmental Fund Projects and the Career Development recipients. The Developmental Fund program supports a steady state of four Developmental Projects, usually of two years duration. We try to stagger the projects so that each year there will be a competition for two new Developmental Fund Projects. However, second year applications are in competition with new applications, and on occasion we will terminate a Developmental Project at the end of the flrst year and initiate three new Developmental Projects in one year. Our Career Development Component provides individual stipends to candidates who want to integrate molecular imaging into their research programs- Career Development funds are recompeted annually. Drs. Herschman and Phelps are advised quarteriy by the Internal Advisory Board (Section B.4), which is made up of past and present ICMIC project directors, and annually by members of the External Advisory Board.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Los Angeles
United States
Zip Code
Kim, Woosuk; Le, Thuc M; Wei, Liu et al. (2016) [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity. Proc Natl Acad Sci U S A 113:4027-32
Faltermeier, Claire M; Drake, Justin M; Clark, Peter M et al. (2016) Functional screen identifies kinases driving prostate cancer visceral and bone metastasis. Proc Natl Acad Sci U S A 113:E172-81
Kirkby, Nicholas S; Chan, Melissa V; Zaiss, Anne K et al. (2016) Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways. Proc Natl Acad Sci U S A 113:434-9
Tavaré, Richard; Escuin-Ordinas, Helena; Mok, Stephen et al. (2016) An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy. Cancer Res 76:73-82
Atefi, Mohammad; Titz, Bjoern; Tsoi, Jennifer et al. (2016) CRAF R391W is a melanoma driver oncogene. Sci Rep 6:27454
Clark, Peter M; Mai, Wilson X; Cloughesy, Timothy F et al. (2016) Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma. Curr Neurol Neurosci Rep 16:17
Zaiss, Anne K; Foley, Erin M; Lawrence, Roger et al. (2016) Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo. J Virol 90:412-20
Barrio, Martin; Czernin, Johannes; Yeh, Michael W et al. (2016) The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients. Nucl Med Commun 37:1290-1296
Mok, Stephen; Tsoi, Jennifer; Koya, Richard C et al. (2015) Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition. BMC Cancer 15:356
Evdokimov, Nikolai M; Clark, Peter M; Flores, Graciela et al. (2015) Development of 2-Deoxy-2-[(18)F]fluororibose for Positron Emission Tomography Imaging Liver Function in Vivo. J Med Chem 58:5538-47

Showing the most recent 10 out of 216 publications